Partial heart transplantation (PHT) is a new surgical option in pediatric cardiac
reconstruction that could address major drawbacks of traditional valve
replacement. Unlike mechanical or bioprosthetic valves and homografts, the living
valve grafts used in PHT can grow with the child. This may help prevent patient–
prosthesis mismatch and reduce the need for repeated surgeries as children grow.
This review covers PHT from concept to clinical application. It discusses the
limitations of current valve replacement methods, the technical success of PHT in
preclinical studies, and early clinical outcomes. The review also examines recent
advances in graft preservation, immunomodulation, 3D modeling, and tissue
engineering that could expand the use of PHT. While PHT is still experimental and
experience is limited, it shows promise as a growth-accommodating option for
some pediatric patients. Background: Current methods for replacing heart valves
have important drawbacks. Prosthetic valves and homografts cannot grow with the
pediatric patient, leading to multiple surgeries. PHT is a new approach that uses
living grafts with valves that can grow and adapt. Objective: This review examines
why and how PHT is applied in practice, its benefits and challenges, and the future
perspectives. Methods: Sources include experimental studies, clinical case reports,
review articles, and meta-analyses on partial heart transplantation, transplantation
immunology, graft preservation, and new tissue engineering methods.
Keywords: heart transplantation; partial heart transplantation; congenital heart
disease; heart valve transplantation; valve replacement; graft preservation;
transplant immunology
